Standout Papers

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole ... 2005 2026 2012 2019 635
  1. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial (2005)
    R. Jakesz, W. Jonat et al. The Lancet
  2. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen (2009)
    Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology

Immediate Impact

54 by Nobel laureates 6 from Science/Nature 107 standout
Sub-graph 1 of 17

Citing Papers

Breast cancer
2021 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
50 intermediate papers

Works of R. Jakesz being referenced

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
2019
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.
2004
and 31 more

Author Peers

Author Last Decade Papers Cites
R. Jakesz 6980 5099 2991 331 11.8k
Shinzaburo Noguchi 5973 5075 2453 383 13.4k
Carl Blomqvist 7401 3842 3131 330 13.5k
Patrick Neven 8402 4330 3048 486 15.2k
Gini F. Fleming 7997 3646 1671 326 16.2k
Vivianne C. G. Tjan‐Heijnen 5306 3435 1104 285 10.4k
Dino Amadori 6535 4179 1045 349 13.9k
Maureen Trudeau 7253 4842 1338 252 12.3k
Eitan Amir 8576 3508 1291 407 14.8k
Henning T. Mouridsen 7858 6558 2495 242 13.8k
Matthew P. Goetz 5378 2997 2228 288 10.6k

All Works

Loading papers...

Rankless by CCL
2026